Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Reports from University of Munich highlight recent research in breast cancer
July 24th, 2008
According to recent research published in the journal Anticancer Research, "The aim of the present prospective case-control study was to evaluate the putative relevance of circulating microparticles (MP) as a biomarker in breast cancer patients. Endothelial cell(EMP) and leukocyte-derived MP (IMP) were determined by flow cytometry in breast cancer patients (n =41) and healthy controls (n=25) and compared to carcinoembryonic antigen (CEA), cancer antigen (CA) 15-3 and von Willebrand factor antigen (vWF) levels by specificity-sensitivity profiles." "LMP, CEA and CA15-3 levels differed significantly between breast cancer patients and controls, whereas EMP and vWF...
Source: Women's Health Weekly (2008-07-24)
|
